Strengthening connections in Boston and Berlin
Our team heads to Boston and Berlin to connect with the international cell and gene therapy community
Next week, our team will be attending two key industry events on both sides of the Atlantic.
On November 4–5, Peter Jähn, PhD, Vice president of Business Development at VIVEbiotech, will be in Boston for Advanced Therapies USA, organized by Terrapinn at the Hynes Convention Center.
As Peter shares in the video, which you can watch on our YouTube channel or LinkedIn, the event will be a great opportunity to meet colleagues, reconnect with familiar faces, and explore new partnerships and collaborations around lentiviral vectors. Attendees can connect with our team through the event’s partnering platform to schedule a meeting.
Meanwhile, Diego Bochoeyer, Chief Operating Officer, and Janire Arizeta, Production Head, will be in Berlin for Cell and Gene Therapy International Europe, organized by Informa and taking place on November 3–5 at Hotel Palace Berlin.
Two cities, two key industry events, and one shared goal: connecting with the international cell and gene therapy community, building collaborations, and ultimately helping advanced therapies reach more patients.
